Epix Pegs Vasovist Approval In Second Half 2007 Following Second “Approvable” Letter

FDA’s action letter for the vascular imaging agent requires an additional clinical trial and a re-read of images from previous trials.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet